Effect of Presence of Uni- or Bilateral Thyroid Adenoma on Recovery of Pituitary–Thyroid Axis and Creatinine Concentration in Radioiodine-Treated Cats

Effect of Presence of Uni- or Bilateral Thyroid Adenoma on Recovery of Pituitary–Thyroid Axis and Creatinine Concentration in Radioiodine-Treated Cats

Radioiodine therapy (RAIT) is the gold standard for treatment of hyperthyroidism in cats. The aim of this study was to evaluate the effect of the presence of uni- or bilateral thyroid adenoma on changes in total thyroxine (TT4), thyroid-stimulating hormone (TSH), and creatinine concentration over a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Anna Paulina Menzel, Joanna Lin, Arne Güssow, Ve Patzelt, Natali Bauer, Katarina Hazuchova
Format:	Article
Language:	English
Published:	MDPI AG 2024-09-01
Series:	Animals
Subjects:	thyroxine thyroid-stimulating hormone iatrogenic hypothyroidism azotaemia chronic kidney disease radioiodine treatment
Online Access:	https://www.mdpi.com/2076-2615/14/18/2627
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prospective Evaluation of the Prevalence and Laboratory Findings in Adult Cats with Low Thyroxine and Increased Thyrotropin Concentration
by: Joanna Lin, et al.
Published: (2024-12-01)

CRITERIA OF WELL-DIFFERENTIATED THYROID CARCINOMA RESISTANCE TO RADIOIODINE THERAPY
by: P. O. Rumyantsev, et al.
Published: (2015-04-01)

A practical approach on radioprotection in the treatment of radioiodine for thyroid cancer
by: Janaína Dutra Silvestre Mendes, et al.
Published: (2018-09-01)

Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
by: J. Nwatsock, et al.
Published: (2012-01-01)

Brain metastasis from differentiated thyroid carcinoma responding to radioiodine therapy
by: Leo Hashimoto, et al.
Published: (2025-07-01)

Radioiodine-resistant metastases of well-differentiated thyroid cancer, analysis of tumor characteristics and primary surgical intervention
by: M. V. Ostafiychuk, et al.
Published: (2021-10-01)

Owners’ Experience and Satisfaction with Radioiodine Treatment in Hyperthyroid Cats—A Prospective Questionnaire Study
by: Sofie Muthmann, et al.
Published: (2025-05-01)

Guidelines for radioiodine therapy in differentiated thyroid cancer and post-therapeutic follow-up
by: A. Yu. Shurinov, et al.
Published: (2024-06-01)

Thyroid Hormone Levels in Patients with Head and Neck Cancer Undergoing Radiochemotherapy: A Retrospective Study
by: Nidhi Rohan Purandare, et al.
Published: (2025-06-01)

A rare case report of delayed thyroxine hypersensitivity: Challenges and management strategies
by: Halimah Hana A Karim, et al.
Published: (2025-05-01)

Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial
by: M. S. Brose, et al.
Published: (2018-07-01)

Effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic review
by: Bima Indra, et al.
Published: (2025-05-01)

Interpretation, differential diagnosis, and clinical implications of abnormal thyroid function tests in children
by: Gözde Akın Kağızmanlı, et al.
Published: (2023-06-01)

Observation and treatment of patients with progressive metastatic differentiated thyroid cancer after establishment of radioiodine refractoriness
by: E. V. Borodavina, et al.
Published: (2024-08-01)

RADIOIODINE THERAPY OF PAPILLARY THYROID CANCER, COMPLICATED BY A RADIAL MYELITIS. CLINICAL CASE
by: L. M. Farkhutdinova
Published: (2018-06-01)

Low risk of thyroid eye disease (TED) following radioiodine (RAI) therapy in a multidisciplinary setting: a retrospective cohort study
by: John S. Vekinis, et al.
Published: (2025-08-01)

Failure of iodine uptake in microscopic pulmonary metastases after recombinant human thyroid-stimulating hormone stimulation
by: Courtney Lawhn-Heath, et al.
Published: (2020-01-01)

Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer
by: Jan Taprogge, et al.
Published: (2025-07-01)

Perioperative Changes in the Pituitary-Adrenal and Pituitary-Thyroid Systems and Their Correction in Females with Severe Gestosis
by: V. M. Zhenilo, et al.
Published: (2006-12-01)

Management of radioiodine ablation therapy in haemodialysis patients with thyroid cancer: a case series of two patients
by: Raymond Lin, et al.
Published: (2025-07-01)

Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective Evaluation
by: Laura Musso, et al.
Published: (2025-03-01)

The Impact of Radioiodine (131I) Therapy of Thyroid Disease on Salivary Glands Function and Inflammation: A Comprehensive Review
by: Pietro Bellini, et al.
Published: (2025-06-01)

Lenvatinib in advanced radioiodine-refractory differentiated thyroid cancer: what’s new?
by: E. V. Borodavina, et al.
Published: (2024-12-01)

Personalized therapy with lenvatinib for progressive radioiodine refractory differentiated thyroid cancer in routine clinical practice
by: P. O. Rumyantsev, et al.
Published: (2021-11-01)

Clinical outcome and influencing factors of differentiated thyroid cancer patients with radioiodine-refractory lung metastasis
by: Congcong Wang, et al.
Published: (2025-08-01)

Comparison of radioiodine ablation rates between low versus high dose, and according to the surgeon's expertise in the low-risk group of differentiated thyroid cancer
by: Ghazal Norouzi, et al.
Published: (2021-03-01)

Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study)
by: Giulia Puliani, et al.
Published: (2025-04-01)

Association between thyroid function and osteopenia or osteoporosis: a cross-sectional study in China
by: Ling Zhang, et al.
Published: (2025-05-01)

Leptin and thyroid hormones in beta-thalassemia major: A cross-sectional study
by: Noor Mohammad Noori, et al.
Published: (2025-06-01)

Gastrointestinal side effects of the radioiodine therapy for the patients with differentiated thyroid carcinoma two days after prescription
by: Mehran Pashnehsaz, et al.
Published: (2016-07-01)

Efficacy and tolerability of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer: results of a multicenter observational study in the Russian Federation
by: E. V. Borodavina, et al.
Published: (2020-04-01)

Selpercatinib in the treatment of medullary and radioiodine-refractory differentiated thyroid cancer with RET mutation (literature review)
by: E. V. Borodavina, et al.
Published: (2025-03-01)

Autoimmune thyroiditis in different age groups and subjects of reproductive age in Adzhariya population
by: N. G. Tchelidze, et al.
Published: (2022-03-01)

The effect of COVID-19 on the presentation of thyroid antibodies. Case report
by: Afrim Zeqiraj
Published: (2024-09-01)

Predicting variables associated with diagnostic reevaluation of transient congenital hypothyroidism
by: Si-Hwa Gwag, et al.
Published: (2025-06-01)

“Tumour sink effect” on the diagnostic or posttreatment radioiodine scan due to sequestration into large-volume functioning metastasis of differentiated thyroid carcinoma influencing uptake in smaller metastatic sites or remnant thyroid tissue: An uncommon but possible phenomenon in thyroid cancer practice
by: Sandip Basu, et al.
Published: (2020-04-01)

The Relationship between Levels of Thyroid-stimulating Hormone and Free Thyroxine and Impaired Outer Hair Cell Function in Pediatric Hypothyroid Patients
by: Agnes Windyasari, et al.
Published: (2025-01-01)

Outcome of Radioiodine Therapy in a West African Population
by: Yetunde Onimode, et al.
Published: (2016-01-01)

EFFECT OF BISPHENOL A ON THYROID, LIVER AND TESTICULAR FUNCTIONS IN ADULT MALE RATS
by: Jassim. M. A. Alkalby
Published: (2015-06-01)

Intramuscular and subcutaneous levothyroxine: success in treating refractory hypothyroidism
by: Nadia Chaudhury, et al.
Published: (2025-04-01)